Atlas Trials

Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation

Clinical trial NCT02113891 · WITHDRAWN

Trial details

NCT number
NCT02113891
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Subclinical Acute Antibody-mediated Rejection in Kidney Transplantation
Start date
2015-02-01
Primary completion
2017-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.